William J. Howitt

Family Medicine
1540 E Evergreen St
Springfield, MO 65803

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions.

Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 27, 2024

Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.

Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.

Journal: EBioMedicine
Published: July 09, 2021
Showing 1-2 of 2

Last Updated: 09/26/2026